- Home
- PCRX vs SEAT Comparison
PCRX vs SEAT Comparison
Compare PCRX & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- SEAT
- Stock Information
- Founded
- PCRX 2006
- SEAT 2001
- Country
- PCRX United States
- SEAT United States
- Employees
- PCRX N/A
- SEAT N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- SEAT Industrial Machinery/Components
- Sector
- PCRX Health Care
- SEAT Industrials
- Exchange
- PCRX Nasdaq
- SEAT Nasdaq
- Market Cap
- PCRX 1.2B
- SEAT 622.1M
- IPO Year
- PCRX 2011
- SEAT N/A
- Fundamental
- Price
- PCRX $26.80
- SEAT $4.37
- Analyst Decision
- PCRX Buy
- SEAT Strong Buy
- Analyst Count
- PCRX 10
- SEAT 10
- Target Price
- PCRX $29.30
- SEAT $6.73
- AVG Volume (30 Days)
- PCRX 892.8K
- SEAT 1.1M
- Earning Date
- PCRX 02-27-2025
- SEAT 03-04-2025
- Dividend Yield
- PCRX N/A
- SEAT N/A
- EPS Growth
- PCRX N/A
- SEAT N/A
- EPS
- PCRX N/A
- SEAT N/A
- Revenue
- PCRX $694,957,000.00
- SEAT $774,076,000.00
- Revenue This Year
- PCRX $5.14
- SEAT $10.17
- Revenue Next Year
- PCRX $2.44
- SEAT $4.02
- P/E Ratio
- PCRX N/A
- SEAT N/A
- Revenue Growth
- PCRX 4.40
- SEAT 13.91
- 52 Week Low
- PCRX $11.16
- SEAT $3.24
- 52 Week High
- PCRX $31.67
- SEAT $6.41
- Technical
- Relative Strength Index (RSI)
- PCRX 77.75
- SEAT 49.56
- Support Level
- PCRX $25.06
- SEAT $4.13
- Resistance Level
- PCRX $27.10
- SEAT $4.78
- Average True Range (ATR)
- PCRX 1.45
- SEAT 0.26
- MACD
- PCRX 0.28
- SEAT -0.08
- Stochastic Oscillator
- PCRX 86.23
- SEAT 26.67
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale.